tirzepatide compound fda lawsuit LATEST UPDATE! compounding! Lawsuit! Overreach? Eli Lilly said on Tuesday
Description
Date : DMF Number : 39655 Submission : 2024-03-17 Status : Active Type : II Product Web Link USDMF GDUFA DMF Review : N/A Rev
Mounjaro belongs to a class of drugs called "dual GIP and GLP-1 receptor agonists", which helps treat both Type 2 Diabetes and obesity effectively
In the middle, vendors like Peptide Sciences occupy the C range
Additionally, the drug acts on appetite centers in the brain, decreasing hunger signals and food cravings
This brings hope to those who want to achieve a healthier body weight
For generic challengers, the standard due diligence process now requires mapping the entire secondary patent portfolio, not just the primary composition-of-matter patents, before committing to ANDA preparation and litigation
